PARP1 and cancer: Results obtained from the GEPIA dataset provided strong evidence that the PARP1 level is upregulated in cancer compared to normal tissues (Fig. 6b), in line with previous data reporting increased copy overexpression of PARP1 in CC and supporting a role for the protein in the malignant progression of the disease [27].